Ginkofar® awarded the consumer quality leader title
Ginkofar® has enjoyed the confidence of patients for over 20 years. It is the undisputed market leader, which is also confirmed by the title of the 2019 consumer quality leader. Biofarm’s strategic focus is on providing products of high quality, therefore, this award make us particularly happy.
Ginkofar® is a product used by patients:
- to improve cognitive abilities in the elderly,
- with age-related impairment of memory and mental concentration,
- to improve the quality of life in mild dementia.
Our OTC drug is available in four dosages, including the only product in Poland in a dosage of 240 mg - Ginkofar® Extra. The effectiveness of our drug has been confirmed by clinical tests *
*Bidzan L, Bilkiewicz A, Turczyński J. Wstępna ocena skuteczności i bezpieczeństwa wyciągu z miłorzębu japońskiego (preparat Ginkofar) w terapii zespołów otępiennych. Psychiatra Polska 2005 May-Jun; 39(3): 599-66.
For improvement of cognitive abilities
Summary of drug characteristics: Ginkofar®
Ginkgo bilobae folium extractum siccum (Ginkgo biloba, dry leaf extract), 40 mg, film-coated tablets.
Indications: to improve cognitive abilities in the elderly (impairment of memory and mental performance associated with age), to improve the quality of life in mild dementia. The product is indicated for use in adults.
Contraindications: Hypersensitivity to the active substance or to any of the excipients, pregnancy.
Marketing Authorization Holder: Biofarm Sp. z o.o., ul. Wałbrzyska 13, 60-198 Poznań, Poland.
Before use, please read the information leaflet, which contains indications, contraindications, data on adverse effects and dosage, as well as information on the use of the medicinal product, or consult a doctor or pharmacist, as any drug used contrary to its purpose can be dangerous to your life and health.
We support the fight against COVID-19